Results 331 to 340 of about 531,871 (379)
Aminoglycoside Drugs as Adjuvants to Enhance siRNA/mRNA Delivery by Lipid Nanoparticles. [PDF]
ACS OmegaSun X, Qian L.
europepmc +1 more source
<i>Rickettsia rickettsii</i> inactivated whole cell antigen vaccine protects against Rocky Mountain spotted fever independent of the adjuvant used. [PDF]
Infect ImmunLatré de Laté P +12 more
europepmc +1 more source
Nanoparticle Delivery of Alu RNA Adjuvants Enhances Vaccine Immunogenicity. [PDF]
ACS Appl Mater InterfacesKwiatkowski AJ +12 more
europepmc +1 more source
Distinct effects of adjuvants on B cell responses to protein or polysaccharide antigens contained in glycoconjugate vaccines. [PDF]
Front ImmunolBudroni S +13 more
europepmc +1 more source
Nanovaccines in gastrointestinal cancers. [PDF]
Front ImmunolWang Y, Huang P, Li C, Tu S, Yang H.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Vaccine, 2005
Induction of immune responses following oral immunization is frequently dependent upon the co-administration of appropriate adjuvants that can initiate and support the transition from innate to adaptive immunity. The three bacterial products with the greatest potential to function as mucosal adjuvants are the ADP-ribosylating enterotoxins (cholera ...
L C, Freytag, J D, Clements
openaire +4 more sources
Induction of immune responses following oral immunization is frequently dependent upon the co-administration of appropriate adjuvants that can initiate and support the transition from innate to adaptive immunity. The three bacterial products with the greatest potential to function as mucosal adjuvants are the ADP-ribosylating enterotoxins (cholera ...
L C, Freytag, J D, Clements
openaire +4 more sources
International Reviews of Immunology, 1990
In summary, HIV vaccine studies described have generally not been designed to measure the effect of the adjuvant or to make comparisons between adjuvants. In only one study was a head-to-head comparison made between HIV antigen alone and antigen formulated with different adjuvants. We hope that future experiments with HIV/SIV vaccine candidates will be
R, Edelman, C O, Tacket
openaire +2 more sources
In summary, HIV vaccine studies described have generally not been designed to measure the effect of the adjuvant or to make comparisons between adjuvants. In only one study was a head-to-head comparison made between HIV antigen alone and antigen formulated with different adjuvants. We hope that future experiments with HIV/SIV vaccine candidates will be
R, Edelman, C O, Tacket
openaire +2 more sources